secwatch / observer
8-K filed January 20, 2026, 6:59 PM ET ticker IVPR CIK 0001939365
debt confidence medium sentiment negative materiality 0.40

Inspire cancels $25K debt by issuing 2.5M shares to Target Capital 1 LLC

INSPIRE VETERINARY PARTNERS, INC.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

INSPIRE VETERINARY PARTNERS, INC. issued 2,500,000 shares of common stock to Target Capital 1 LLC.

Security
common stock
Shares
2,500,000 shares
Purchaser
Target Capital 1 LLC
Exact text from the filing
the Company and Target agreed to cancel $25,000 of the outstanding principal amount under that certain promissory note issued by the Company to Target on June 10, 2025, as amended (the “June Note”), in exchange for 2,500,000 shares of the Company’s Class A common stock
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INSPIRE VETERINARY PARTNERS, INC. entered into Cancellation and Exchange Agreement with Target Capital 1 LLC valued at $25,000 (effective 2026-01-14).

Action
entry
Agreement
equity purchase
Counterparty
Target Capital 1 LLC
Value
$25,000
Effective
2026-01-14
Exact text from the filing
On January 14, 2026, Inspire Veterinary Partners, Inc. (the “Company”), entered into a Cancellation and Exchange Agreement, (the “Agreement”) with Target Capital 1 LLC ( “Target”). Pursuant to the Agreement, the Company and Target agreed to cancel $25,000 of the outstanding principal amount under that certain promissory note issued by the Company to Target on June 10, 2025, as amended (the “June Note”), in exchange for 2,500,000 shares of the Company’s Class A common stock, par value $0.0001 per share.
View on SEC.gov

Browse all equity issuances →

INSPIRE VETERINARY PARTNERS, INC. filing history →

Source: SEC EDGAR
accession 0001213900-26-005532
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.